Successful immune checkpoint inhibitor‐based rechallenge in a patient with advanced esophageal squamous cell cancer: A case report

Abstract Immune checkpoint inhibitors (ICIs) have been shown to improve survival in patients with advanced or metastatic esophageal cancer. However, ICI‐based rechallenges after recovery from fatal adverse events (AEs) are equivocal, especially in patients who have already undergone treatment‐relate...

Full description

Bibliographic Details
Main Authors: Yanhong Yao, Zhentao Liu, Qian Li, Baoshan Cao, Mopei Wang
Format: Article
Language:English
Published: Wiley 2022-02-01
Series:Thoracic Cancer
Subjects:
Online Access:https://doi.org/10.1111/1759-7714.14279

Similar Items